Medical marijuana in HIV-positive patients: what do we know?
Medical marijuana in HIV-positive patients: what do we know?
复制标题
DOI：
10.1177/1545109709351167
复制
发表时间：
2009-11-01
期刊：
影响因子：
--
通讯作者：
Cinti, Sandro
中科院分区：
文献类型：
--
作者：
Cinti, Sandro
2008年11月4日，我们州通过了《密歇根州医用大麻法案》(MMMA)，允许在某些情况和/或一系列症状下医用大麻。本文将(1)回顾目前证明医用大麻对某些慢性疾病有用的证据，特别是艾滋病毒阳性者所经历的疼痛和消耗综合症；(2)讨论大麻的不良影响；(3)总结密歇根州的新法律及其对医生构成的挑战；(4)回顾自1996年以来医用大麻已合法化的加利福尼亚州的经验。
On November 4, 2008, our state passed the Michigan Medical Marijuana Act (MMMA), which allows the medical use of marijuana for certain conditions and/or constellation of symptoms. This article will (1) review the current evidence that medical marijuana is useful for certain chronic conditions, particularly pain and wasting syndromes experienced by HIV-positive people; (2) discuss the adverse effects of marijuana; (3) summarize the new Michigan law and the challenges it poses for physicians, and (4) review the experience in California where medical marijuana has been legal since 1996.